AAgAtlas 1.0: a human autoantigen database

Autoantibodies refer to antibodies that target self-antigens, which can play pivotal roles in maintaining homeostasis, distinguishing normal from tumor tissue and trigger autoimmune diseases. In the last three decades, tremendous efforts have been devoted to elucidate the generation, evolution and functions of autoantibodies, as well as their target autoantigens. However, reports of these countless previously identified autoantigens are randomly dispersed in the literature. Here, we constructed an AAgAtlas database 1.0 using text-mining and manual curation. We extracted 45 830 autoantigen-related abstracts and 94 313 sentences from PubMed using the keywords of either ‘autoantigen’ or ‘autoantibody’ or their lexical variants, which were further refined to 25 520 abstracts, 43 253 sentences and 3984 candidates by our bio-entity recognizer based on the Protein Ontology. Finally, we identified 1126 genes as human autoantigens and 1071 related human diseases, with which we constructed a human autoantigen database (AAgAtlas database 1.0). The database provides a user-friendly interface to conveniently browse, retrieve and download human autoantigens as well as their associated diseases. The database is freely accessible at http://biokb.ncpsb.org/aagatlas/. We believe this database will be a valuable resource to track and understand human autoantigens as well as to investigate their functions in basic and translational research.

[1]  Andrew J. G. Simpson,et al.  CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens , 2008, Nucleic Acids Res..

[2]  S. Hanash,et al.  Emerging molecular biomarkers—blood-based strategies to detect and monitor cancer , 2011, Nature Reviews Clinical Oncology.

[3]  Debashis Ghosh,et al.  Autoantibody signatures in prostate cancer. , 2005, The New England journal of medicine.

[4]  José Luís Oliveira,et al.  BeCAS: biomedical concept recognition services and visualization , 2013, Bioinform..

[5]  E. Lundberg,et al.  A chromosome-centric analysis of antibodies directed toward the human proteome using Antibodypedia. , 2014, Journal of proteome research.

[6]  Gang Fu,et al.  Disease Ontology 2015 update: an expanded and updated database of human diseases for linking biomedical knowledge through disease data , 2014, Nucleic Acids Res..

[7]  Peter D. Burbelo,et al.  New autoantibody detection technologies yield novel insights into autoimmune disease , 2014, Current opinion in rheumatology.

[8]  Ying Zhang,et al.  The neXtProt knowledgebase on human proteins: current status , 2014, Nucleic Acids Res..

[9]  Fuchu He,et al.  Mapping and analyzing the human liver proteome: progress and potential , 2016, Expert review of proteomics.

[10]  Alan B Hollingsworth,et al.  Integration of Serum Protein Biomarker and Tumor Associated Autoantibody Expression Data Increases the Ability of a Blood-Based Proteomic Assay to Identify Breast Cancer , 2016, PloS one.

[11]  Joshua LaBaer,et al.  Proteomic mapping of p53 immunogenicity in pancreatic, ovarian, and breast cancers , 2016, Proteomics. Clinical applications.

[12]  Richard Van Noorden Trouble at the text mine , 2012, Nature.

[13]  N. Shah,et al.  NCBO Annotator: Semantic Annotation of Biomedical Data , 2009 .

[14]  Quchang Ouyang,et al.  HER2-positive double primary tumor of gastric and breast cancer occur synchronously in a patient: A case report , 2016, Molecular and clinical oncology.

[15]  Jian Zhang,et al.  Protein Ontology: a controlled structured network of protein entities , 2013, Nucleic Acids Res..

[16]  Elspeth A. Bruford,et al.  Genenames.org: the HGNC resources in 2015 , 2014, Nucleic Acids Res..

[17]  Peter Wiktor,et al.  A Contra Capture Protein Array Platform for Studying Post-translationally Modified (PTM) Auto-antigenomes* , 2016, Molecular & Cellular Proteomics.

[18]  Gerben Menschaert,et al.  PubMeth: a cancer methylation database combining text-mining and expert annotation , 2007, Nucleic Acids Res..

[19]  Peter Nilsson,et al.  Anoctamin 2 identified as an autoimmune target in multiple sclerosis , 2016, Proceedings of the National Academy of Sciences.

[20]  David R. Karp,et al.  Autoantibodies and SLE—the threshold for disease , 2014, Nature Reviews Rheumatology.

[21]  William R. Hersh,et al.  A survey of current work in biomedical text mining , 2005, Briefings Bioinform..

[22]  Yu Zhang,et al.  HPtaa database-potential target genes for clinical diagnosis and immunotherapy of human carcinoma , 2005, Nucleic Acids Res..

[23]  P. Plotz,et al.  The autoantibody repertoire: searching for order , 2003, Nature Reviews Immunology.

[24]  Renier J. Brentjens,et al.  Driving CAR T-cells forward , 2016, Nature Reviews Clinical Oncology.

[25]  Joshua Labaer,et al.  Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer. , 2011, Journal of proteome research.

[26]  Henning Hermjakob,et al.  The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..

[27]  Paolo Casali,et al.  Nature and functions of autoantibodies , 2008, Nature Clinical Practice Rheumatology.

[28]  W. Cho,et al.  Application of proteomics in non-small-cell lung cancer , 2016, Expert review of proteomics.

[29]  Joshua LaBaer,et al.  Plasma Autoantibodies Associated with Basal-like Breast Cancers , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[30]  Anushya Muruganujan,et al.  PANTHER version 10: expanded protein families and functions, and analysis tools , 2015, Nucleic Acids Res..

[31]  Eshel Ben-Jacob,et al.  Organization of the autoantibody repertoire in healthy newborns and adults revealed by system level informatics of antigen microarray data , 2009, Proceedings of the National Academy of Sciences.

[32]  B. Stewart,et al.  World cancer report 2014. , 2014 .

[33]  Michael Haberl,et al.  Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease , 2016, Proceedings of the National Academy of Sciences.

[34]  Tatiana A. Tatusova,et al.  Gene: a gene-centered information resource at NCBI , 2014, Nucleic Acids Res..

[35]  Jian Zhang,et al.  The Protein Ontology: a structured representation of protein forms and complexes , 2010, Nucleic Acids Res..

[36]  H. Komatsu [Antibody therapy in cancer]. , 2010, Nihon rinsho. Japanese journal of clinical medicine.

[37]  Rajagopal N. Aravalli,et al.  Molecular mechanisms of hepatocellular carcinoma , 2008, Hepatology.

[38]  Sarah C. Ayling,et al.  The Ensembl gene annotation system , 2016, Database J. Biol. Databases Curation.

[39]  I. Xenarios,et al.  UniProtKB/Swiss-Prot, the Manually Annotated Section of the UniProt KnowledgeBase: How to Use the Entry View. , 2016, Methods in molecular biology.

[40]  Xiaobo Yu,et al.  Advancing translational research with next‐generation protein microarrays , 2016, Proteomics.

[41]  H. Bartsch,et al.  International Agency for Research on Cancer. , 1969, WHO chronicle.

[42]  J. Jett,et al.  udit of the autoantibody test , EarlyCDT ®-Lung , in 1600 patients : n evaluation of its performance in routine clinical practice , 2014 .

[43]  Gang Feng,et al.  Disease Ontology: a backbone for disease semantic integration , 2011, Nucleic Acids Res..